People in the News


EraGen said this week that Ronald Dunn has been appointed as vice president of quality, regulatory, and clinical affairs.

Dunn most recently served as director of global quality and regulatory with Regulatory Compliance Associates, a Kenosha, Wis.-based consulting firm. He has also held senior management positions in quality assurance at Invitrogen and Bone Care International (later acquired by Genzyme). Dunn was also a senior manager of quality assurance and regulatory compliance with Third Wave Technologies.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The ancestors of the Arizona bark scorpion and other scorpions and spiders underwent whole-genome duplication, KJZZ reports.

A cryptographic approach could help researchers keep genomic data private while researchers analyze it, Scientific American reports.

Andy Page, the former president of 23andMe, has joined a diabetes-management startup, according to CNBC.

In Cell this week: regulatory changes in pancreatic cancer, metabolic shifts in Alzheimer's disease, and more.